Who owns BIONDVAX PHARMACEUTICALS LTD?
- Ticker: SCNI
- CUSIP Number: 09073q303
Tip: Access positions for across all investors
Analyze quarterly positions in Biondvax Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Biondvax Pharmaceuticals stock
Who bought or sold BIONDVAX PHARMACEUTICALS LTD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| XTX Topco | 27k | $19k | 100% | Dec 2025 |
|
| Virtu Financial | 15k | $11k | 100% | Dec 2025 |
|
| Rhumbline Advisers | 1.9k | $1.0k | 0% | Mar 2026 |
|
| UBS Group | 919.00 | $524.013800 | -47% | Mar 2026 |
|
| Morgan Stanley | 58.00 | $33.002000 | 0% | Mar 2026 |
|
Who sold out of Biondvax Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Citadel Advisors | Dec 2025 | 35k | $25k |
| Northwestern Mutual Wealth Management Company | Dec 2025 | 1.0k | $712.000000 |